Skip to Main Content

Author Details

Abisola Abisoye-Ogunniyan
Lawrence Livermore National Laboratory
2016
8
5
PMIDPaper TitleJournal TitlePublished Year
36992088The Polymorphic Membrane Protein G Has a Neutral Effect and the Plasmid Glycoprotein 3 an Antagonistic Effect on the Ability of the Major Outer Membrane Protein to Elicit Protective Immune Responses against a <i>Chlamydia muridarum</i> Respiratory Challenge.Vaccines (Basel)2023
36992088The Polymorphic Membrane Protein G Has a Neutral Effect and the Plasmid Glycoprotein 3 an Antagonistic Effect on the Ability of the Major Outer Membrane Protein to Elicit Protective Immune Responses against a <i>Chlamydia muridarum</i> Respiratory Challenge.Vaccines (Basel)2023
34899322A Survey of Preclinical Studies Evaluating Nanoparticle-Based Vaccines Against Non-Viral Sexually Transmitted Infections.Front Pharmacol2021
34899322A Survey of Preclinical Studies Evaluating Nanoparticle-Based Vaccines Against Non-Viral Sexually Transmitted Infections.Front Pharmacol2021
33037194Concepts of extracellular matrix remodelling in tumour progression and metastasis.Nat Commun2020
32051227Mannose receptor (CD206) activation in tumor-associated macrophages enhances adaptive and innate antitumor immune responses.Sci Transl Med2020
31931447LC-MS/MS assay coupled with carboxylic acid magnetic bead affinity capture to quantitatively measure cationic host defense peptides (HDPs) in complex matrices with application to preclinical pharmacokinetic studies.J Pharm Biomed Anal2020
33037194Concepts of extracellular matrix remodelling in tumour progression and metastasis.Nat Commun2020
31931447LC-MS/MS assay coupled with carboxylic acid magnetic bead affinity capture to quantitatively measure cationic host defense peptides (HDPs) in complex matrices with application to preclinical pharmacokinetic studies.J Pharm Biomed Anal2020
32051227Mannose receptor (CD206) activation in tumor-associated macrophages enhances adaptive and innate antitumor immune responses.Sci Transl Med2020
29751044Transcriptional repressor Kaiso promotes epithelial to mesenchymal transition and metastasis in prostate cancer through direct regulation of miR-200c.Cancer Lett2018
29751044Transcriptional repressor Kaiso promotes epithelial to mesenchymal transition and metastasis in prostate cancer through direct regulation of miR-200c.Cancer Lett2018
28460635Transcriptomic profiling and quantitative high-throughput (qHTS) drug screening of CDH1 deficient hereditary diffuse gastric cancer (HDGC) cells identify treatment leads for familial gastric cancer.J Transl Med2017
28460635Transcriptomic profiling and quantitative high-throughput (qHTS) drug screening of CDH1 deficient hereditary diffuse gastric cancer (HDGC) cells identify treatment leads for familial gastric cancer.J Transl Med2017
26962861Whole Genome Sequencing of Newly Established Pancreatic Cancer Lines Identifies Novel Somatic Mutation (c.2587G&gt;A) in Axon Guidance Receptor Plexin A1 as Enhancer of Proliferation and Invasion.PLoS One2016
26962861Whole Genome Sequencing of Newly Established Pancreatic Cancer Lines Identifies Novel Somatic Mutation (c.2587G&gt;A) in Axon Guidance Receptor Plexin A1 as Enhancer of Proliferation and Invasion.PLoS One2016
  • 1 - 16 of 16

Recommended Authors

Yale School of Public Health
Career Start Year 2012
Number of shared co-authors 0
University Institute of Pharma Sciences, Chandigarh University
Career Start Year 2011
Number of shared co-authors 0
The University of Texas MD Anderson Cancer Center
Career Start Year 2010
Number of shared co-authors 1
University of British Columbia
Career Start Year 2009
Number of shared co-authors 0
University of North Carolina at Chapel Hill
Career Start Year 2009
Number of shared co-authors 0
Cedars-Sinai Medical Center
Career Start Year 2008
Number of shared co-authors 0
School of Pharmacy, University of Wisconsin-Madison
Career Start Year 2008
Number of shared co-authors 0
Center for Comparative Medicine, Baylor College of Medicine
Career Start Year 2008
Number of shared co-authors 0
Institute of Biomedical Science and Children's Hospital, Fudan University
Career Start Year 2006
Number of shared co-authors 0
Juravinski Cancer Centre
Career Start Year 2006
Number of shared co-authors 0
Walter and Eliza Hall Institute of Medical Research
Career Start Year 2006
Number of shared co-authors 1
University of California san francisco
Career Start Year 2005
Number of shared co-authors 0
Agricultural Genomics Institute at Shenzhen, Chinese Academy of Agricultural Sciences
Career Start Year 2005
Number of shared co-authors 0
University of British Columbia
Career Start Year 2004
Number of shared co-authors 0
University of California
Career Start Year 2003
Number of shared co-authors 0
The Wistar Institute
Career Start Year 2003
Number of shared co-authors 0
University of Toronto
Career Start Year 2002
Number of shared co-authors 0
Adelaide Medical School, University of Adelaide
Career Start Year 2002
Number of shared co-authors 0
19University of Wisconsin Carbone Cancer Center.
Career Start Year 2000
Number of shared co-authors 0
Institute for Human Genetics, University of California san francisco
Career Start Year 1998
Number of shared co-authors 0
The Ohio State University
Career Start Year 1997
Number of shared co-authors 0
The University of Melbourne, Peter MacCallum Cancer Centre
Career Start Year 1996
Number of shared co-authors 0
David Geffen School of Medicine, University of California los angeles
Career Start Year 1995
Number of shared co-authors 0
Odette Cancer Centre, University of Toronto
Career Start Year 1995
Number of shared co-authors 0
Zhengzhou University
Career Start Year 1992
Number of shared co-authors 0
Instituto do Cancer do Estado de Sao Paulo, Faculdade de Medicina de Sao Paulo
Career Start Year 1989
Number of shared co-authors 0
Royal Melbourne Hospital, The University of Melbourne
Career Start Year 1989
Number of shared co-authors 0
Weill-Cornell School of Medicine
Career Start Year 1989
Number of shared co-authors 0
Michigan Center for Translational Pathology, University of Michigan ann arbor
Career Start Year 1988
Number of shared co-authors 0
Queen's University
Career Start Year 1982
Number of shared co-authors 0

Collaborators

Center for Cancer Research, National Cancer Institute
Co-authored papers 4
Center for Cancer Research, National Cancer Institute
Co-authored papers 2
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 2
National Institutes of Health, National Center for Advancing Translational Sciences
Co-authored papers 2
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 1
National Center for Advancing Translational Sciences
Co-authored papers 1
David Geffen School of Medicine, University of California los angeles
Co-authored papers 1
Lawrence Livermore National Laboratory
Co-authored papers 1
University of Alabama at Birmingham
Co-authored papers 1
Chalmers University of Technology
Co-authored papers 1
National Cancer Institute
Co-authored papers 1
National Center for Advancing Translational Sciences, National Institutes of Health
Co-authored papers 1
Center for Cancer Research, National Cancer Institute
Co-authored papers 1
Center for Cancer Research, National Cancer Institute
Co-authored papers 1
Vertex Pharmaceuticals
Co-authored papers 1
From Foundation Medicine
Co-authored papers 1
Johns Hopkins School of Medicine, National Cancer Institute, Princeton University, University of Colorado Anschutz Medical Campus, University of Pittsburgh, University of Washington
Co-authored papers 1
Co-authored papers 1
University of Washington
Co-authored papers 1
INSERM U, PSL Research University, Institut Curie Research Center
Co-authored papers 1
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 1
Center for Cancer Research, National Cancer Institute
Co-authored papers 1
Co-authored papers 1